Effect of Depression, Anxiety and Stress Scores on Embryo Transfer Success

February 17, 2024 updated by: Eurofertil IVF Health Center
Psychological status of couples attending to IVF programmes is important due to possible effect on final result. Observers aim to investigate the depression, anxiety and stress scores of couples before and after the procedure.

Study Overview

Status

Completed

Conditions

Intervention / Treatment

Detailed Description

Studying effect of psychology on IVF is not a new idea. "Before and after" scores of women attending to IVF programmes had been studied numerous times. However, there is not sufficient data about the contbibution of male compartment upon the process. Investigators aimed to study both male and female participants. Final scores will not be evaluated unless at least good quality blastocsyt is transferred.

Study Type

Observational

Enrollment (Actual)

150

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Bursa, Turkey, 16000
        • Eurofertil

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

20 years to 40 years (Adult)

Accepts Healthy Volunteers

N/A

Sampling Method

Non-Probability Sample

Study Population

Women ages 20-40, without history of RIF or known genetic aneuploidy. Men without severe sperm problem without known genetic aneuploidiy. Only blastocyst transferred copules will be eligible for final analysis.

Description

Inclusion Criteria:

  • 20 to 40 year old women attending to IVF programme

Exclusion Criteria:

  • Azospermia and severe male factor for whom sperm freezing will be required
  • History of RIF
  • Known genetik abnormality of couples

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Observational Models: Cohort
  • Time Perspectives: Prospective

Cohorts and Interventions

Group / Cohort
Intervention / Treatment
1 women attending IVF programme
Women attending to IVF programme will be evaluated for pscyhological parameters before and after the precedure
two questionaires for each group
2 partners of women attending to IVF programme
Men who are partners of women attending to IVF programme will be evaluated for pscyhological parameters before and after the precedure
two questionaires for each group

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
positive pregnancy test
Time Frame: 12 days after embryo transfer
blood test will be taken after embryo (blastocyst) transfer
12 days after embryo transfer

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Study Director: gerçek aydın, Eurofertil IVF Health Center

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

March 1, 2022

Primary Completion (Actual)

February 17, 2024

Study Completion (Actual)

February 17, 2024

Study Registration Dates

First Submitted

December 27, 2022

First Submitted That Met QC Criteria

December 27, 2022

First Posted (Actual)

January 12, 2023

Study Record Updates

Last Update Posted (Actual)

February 20, 2024

Last Update Submitted That Met QC Criteria

February 17, 2024

Last Verified

February 1, 2024

More Information

Terms related to this study

Additional Relevant MeSH Terms

Other Study ID Numbers

  • IVF- Stress

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

UNDECIDED

IPD Plan Description

will be evaluated upon request

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Stress

Clinical Trials on questionaire

Subscribe